MeSH tree: N05.715.360.575.575
Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced ...
Jun 2, 2025
0
21
First-line treatment with the triplet combination of encorafenib, cetuximab and mFOLFOX6 significantly improved survival compared to the standard of care in patients with BRAF V600E-mutated metastatic colorectal cancer, according ...
May 30, 2025
0
21
For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of Brain and Behavior.
May 21, 2025
0
15
A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at ...
May 12, 2025
0
22
A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission.
May 9, 2025
0
25
Artificial intelligence (AI) tools significantly improve the readability of online patient education materials (PEMs), making them more accessible, a new study shows.
Apr 30, 2025
0
17
Narrowband UVB (nbUVB) phototherapy may be underutilized in pediatric vitiligo, according to a study published online March 18 in Pediatric Dermatology.
Apr 8, 2025
0
17
Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can accurately choose more effective treatments and lead to improved outcomes for patients with platinum-resistant ...
Apr 4, 2025
0
47
An international team of researchers, including experts from the University of Adelaide, has found genomic testing and targeted therapies for patients with advanced cancer could improve survival rates by up to 40%.
Apr 2, 2025
0
15
Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical trials for glioblastoma, a type of brain tumor. Recently, the items have become more diverse, with ...
Mar 21, 2025
0
17
